Evidence map›Paper›PMID 21521341›Full record

Trial reportClinical endocrinology2011

Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids.

Catherine M Jankowski, Wendolyn S Gozansky, Rachael E Van Pelt, Pamela Wolfe, Robert S Schwartz, Wendy M Kohrt

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Catherine M JankowskiDivision of Geriatric Medicine, University of Colorado Denver, Aurora, CO 80045-2527, USA.
Wendolyn S Gozansky
Rachael E Van Pelt
Pamela Wolfe
Robert S Schwartz
Wendy M Kohrt
University of Colorado Denver · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Paul S. Maclean · 1995 to 2026
$32.6M
University of Colorado Aging Training GrantT32AG000279 · NIA · UNIVERSITY OF COLORADO DENVER · PI Kerrie Moreau · 2001 to 2026
$10.1M
COX Inhibition & Musculoskeletal Responses to ExerciseR01AG018857 · NIA · UNIVERSITY OF COLORADO DENVER · PI KOHRT, WENDY M · 2000 to 2010
$4.0M
ESTROGEN, INSULIN AND REGIONAL LIPOLYSIS IN OLDER WOMENK01AG019630 · NIA · UNIVERSITY OF COLORADO DENVER · PI VAN PELT, RACHAEL E · 2002 to 2006
$585k
MECHANISMS OF VISCERAL FAT ACCUMULATION IN OLDER WOMENF32AG005899 · NIA · UNIVERSITY OF COLORADO DENVER · PI GOZANSKY, WENDOLYN S · 2000 to 2002
$144k
NCRR NIH HHS UL1 RR025780NIA NIH HHS F32 AG005899NIA NIH HHS K01 AG019630NIA NIH HHS R01 AG018857NIA NIH HHS T32 AG000279NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

objectiveTo determine the effects of dehydroepiandrosterone (DHEA) therapy on changes in central adiposity, insulin action and blood lipids. Many of the actions of DHEA in humans are thought to be mediated through its conversion to sex hormones, which are modulators of adiposity, muscularity and insulin sensitivity. The effects of DHEA replacement on regional tissue composition, glucose metabolism and blood lipid profile in older adults have been inconsistent.

designA randomized, double-blinded, placebo-controlled trial. The intervention was oral DHEA 50 mg/day or placebo for 12 months.

participantsFifty-eighty women and 61 men, aged 60-88 years, with low serum DHEA sulphate (DHEAS) levels at study entry. MEASUREMENTS: Computed tomography measures of abdominal fat areas, thigh muscle and fat areas, DXA-derived trunk fat mass, serum glucose and insulin responses to an oral glucose challenge, and fasted serum total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides were assessed before and after the intervention.

resultsThere were no significant (P > 0·05) differences between the DHEA and placebo groups in the changes in regional tissue composition or glucose metabolism. HDL-cholesterol (P = 0·01) and fasted triglycerides (P = 0·02) decreased in women and men taking DHEA.

conclusionRestoring serum DHEAS levels in older adults to young adult levels for 1 year does not appear to reduce central adiposity or improve insulin action. The benefit of DHEA on decreasing serum triglycerides must be weighed against the HDL-lowering effect.

Indexed as

Absorptiometry, PhotonAdiposityAgedAged, 80 and overCholesterolCholesterol, HDLCholesterol, LDLDehydroepiandrosteroneFemaleGlucoseHumansLipidsMaleMiddle AgedPlacebosTriglyceridesCholesterolCholesterol, HDLCholesterol, LDLDehydroepiandrosteroneGlucoseLipidsPlacebosTriglycerides

Identifiers

PMID21521341
PMCPMC3166648
OpenAlexW1924799945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.